Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma. Muller F, Schwingen NR, Hagen M, Scholz JK, et al. Blood 2025 Jun 12:blood.2025028375. doi: 10.1182/blood.2025028375.

Read + Share

Amedeo Smart

Independent Medical Education

Muller F, Schwingen NR, Hagen M, Scholz JK, et al. Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma. Blood 2025 Jun 12:blood.2025028375. doi: 10.1182/blood.2025028375.
PMID: 40504989